Clinical Trials Directory

Trials / Completed

CompletedNCT05814302

Treatment Of Fever In The Emergency Department

Treatment Of Fever And Associated Symptoms In The Emergency Department: Which Drug To Choose?

Status
Completed
Phase
Study type
Observational
Enrollment
324 (actual)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years – 95 Years
Healthy volunteers
Not accepted

Summary

Fever is a frequent cause of admission to the Emergency Department (ED) around the world. While it can be caused by a wide range of conditions, the most effective treatment based on its etiology is still undetermined. This observational, prospective, single-center study enrolled adult patients who accessed the ED for fever, with the aim to define the most effective treatment for them.

Detailed description

Physicians were free to administer paracetamol 1000 mg (P), the combination paracetamol 500 mg/ibuprofen 150 mg (PI) or Ibuprofen 600 mg (I).The primary endpoint was both 1-degree and 1-point reduction in body temperature for all associated symptoms on the Numeric Rating Scale (NRS) after 1 hour (T1). Secondary endpoint was the reduction of at least 2 points on the NRS after two hours (T2). Adverse events, the needing of a rescue therapy and the response based on the underlying etiology (bacterial, viral, or immune/neoplastic) were also evaluated.

Conditions

Interventions

TypeNameDescription
DRUGParacetamolEmergency physicians were free to administer paracetamol 1000 mg (P), the combination paracetamol 500 mg/ibuprofen 150 mg (PI) or Ibuprofen 600 mg (I)

Timeline

Start date
2021-06-01
Primary completion
2022-06-01
Completion
2022-07-01
First posted
2023-04-14
Last updated
2023-04-14

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05814302. Inclusion in this directory is not an endorsement.